AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
The rule would ensure Medicare coverage of newly approved breakthrough devices, but have stricter evidence standards.
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
What the equity rule is, who it affects, and how to comply.
Despite lessons learned from COVID-19 testing, HHS and FDA plan for monkeypox testing remains flawed.
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.
A recent study shows that combined cardiomyopathy and arrhythmia genetic testing catches things disease-specific testing would miss.